Drug Database
J07BB02 influenza, inactivated, split virus or surface antigen
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Adjuvanted Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) Seqirus suspension for injection in pre-filled syringe Influenza vaccine, Adjuvanted with MF59C.1 ▼
- POM Adjuvanted Trivalent Influenza Vaccine (Surface Antigen, Inactivated) Suspension for Injection in Pre-filled Syringe Influenza Vaccine, Adjuvanted with MF59C.1
- POM Cell-based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) Seqirus suspension for injection in pre-filled syringe ▼
- POM Fluad Tetra - Northern Ireland ▼
- POM Fluad Tetra suspension for injection in pre-filled syringe ▼
- POM Fluad, Influenza vaccine surface antigen, inactivated, adjuvanted with MF59C.1
- POM Flucelvax tetra
- POM Flucelvax Tetra - Northern Ireland ▼
- POM Influenza vaccine Tetra MYL
- POM Influvac sub-unit Tetra
- POM Quadrivalent Influenza vaccine (Split virion, inactivated)
- POM Supemtek solution for injection in pre-filled syringe ▼
- POM Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).